Vaccines for respiratory syncytial virus (RSV) reduce the risk of infection in older adults and infants, according to a new Cochrane review.
Global Stories, Viral News
Vaccines for respiratory syncytial virus (RSV) reduce the risk of infection in older adults and infants, according to a new Cochrane review.